# Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy

> **NCT03914404** · PHASE4 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** γ-linoleic acid and placebo(Thioctic Acid)
- **DRUG:** Thioctic Acid and placebo(γ-linoleic acid)

## Key facts

- **NCT ID:** NCT03914404
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-26
- **Primary completion:** 2016-03-30
- **Final completion:** 2018-07-25
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914404, "Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03914404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*